Distribution of colorectal adenomas: implications for bowel cancer screening

Nicholson, Fiona B; Korman, Melvyn G; Stern, Anthony I; Hansky, Jack

Topics

Neoplasms

Digestive system diseases

Distribution of colorectal adenomas: implications for bowel cancer screening

Correspondence:

1.
Coates M, Day P, McCredie M. Cancer in New South Wales: incidence and mortality 1992. Sydney: NSW Cancer Council, 1995.
2.
Australian Institute of Health and Welfare and the Australasian Association of Cancer Registries. Cancer in Australia 1991-1994 (with projections to 1999). Canberra: AIHW, 1998.
3.
Muto T, Bussey H, Morson B. The evolution of cancer in the colon and rectum. Cancer 1975; 36: 2251-2270.
4.
Winawer S. The National Polyp Study. Design, methods, and characteristics of patients with newly diagnosed polyps. The National Polyp Study Workgroup. Cancer 1992; 70: 1236-1245.
5.
National Health and Medical Research Council. Clinical practice guidelines. The prevention, early detection and management of colorectal cancer. Canberra: NHMRC, 1999.
6.
Australian Health Technology Advisory Committee. Colorectal cancer screening. Canberra: AGPS, 1997.
7.
Gut Foundation of Australia. Colorectal cancer prevention, diagnosis and treatment (public information booklet). Sydney: The Foundation, 1999.
8.
Winawer S, Fletcher R, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997; 112: 594-642.
9.
Kadakia S, Wrobleski C, Kadakia A. Prevalence of proximal colonic polyps in average-risk asymptomatic patients with negative fecal occult blood tests and flexible sigmoidoscopy. Gastrointest Endosc 1996; 44: 112-117.
10.
Shah S, Saunders B, Brooker J, Williams C. What happens during routine colonoscopy? An audit using magnetic positional imaging (MPI). Gut 1999; 44 Suppl 1: A105.
11.
Jacobs J, Burke C, Larive B. 60 cm flexible sigmoidoscopy, how far do we really get? [abstract] Gastroenterology 1999; 116 (4 Pt 2): A428.
12.
Collett J, Platell C, Fletcher D, et al. Distal colonic neoplasms predict proximal neoplasia in average-risk, asymptomatic subjects. J Gastroenterol Hepatol 1999; 14: 67-71.
13.
Rex D, Amitabh C, Vasudeva R. Prospective determination of distal colon findings in average-risk patients with proximal colon cancer. Gastrointest Endosc 1999; 49: 727-730.
14.
Basson M, Etter L, Panzini L. Rates of colonoscopic perforation in current practice. Gastroenterology 1998; 114: 1115.
15.
Rex D, Lehman G, Ulbright T, et al. Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender and family history. Am J Gastroenterol 1993; 88: 825-831.
16.
Mandel J, Bond J, Church T. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993; 328: 1365-1371.
17.
Hardcastle J, Chamberlain J, Robinson M, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-1477.
18.
Bolin T, Korman M, Stanton R. Positive cost effectiveness of early diagnosis of colorectal cancer. Colorectal Dis 1999; 1: 113-122.
19.
Bolin T, Korman M. How can we reduce the incidence and mortality of colorectal cancer? Med J Aust 1997; 166: 175-176.

Online responses are no longer available. Please refer to our instructions for authors page for more information.